Latest University of Pennsylvania School Stories
Soccer referees may have an unconscious bias towards calling fouls based on a play's direction of motion.
A novel therapy designed to attack tumors in patients with a genetic mutation in either BRCA1 or BRCA2, slowed tumor growth in 85 percent of advanced breast cancer patients treated in a small study.
An Ethical and Clinical Exploration of the Pros & Cons of Robotic Surgery PHILADELPHIA, June 11 /PRNewswire-USNewswire/ -- Robotic surgery -- is it truly an advance for modern medicine, or just a product of slick consumer advertising campaigns and targeted marketing to physicians? Advocates say robots help surgeons perform surgery with greater access, visibility and precision all which reduce pain and blood loss, shortening hospital stays and ultimately getting patients back to work and...
Using high-throughput sequencing to map the locations of a common type of jumping gene within a person's entire genome, researchers at the University of Pennsylvania School of Medicine found extensive variation in these locations among the individuals they studied, further underscoring the role of these errant genes in maintaining genetic diversity.
Stages from early to mature cell offer clues for anti-obesity drug development.
So often the rare informs the common. Penn researchers investigating a regulatory protein involved in a rare genetic disease have shown that it may be related to epileptic and autistic symptoms in other more common neurological disorders.
Penn Also Stands among the Top Five Nationally for Pediatrics, Women's Health, Internal Medicine and Drug/Alcohol Abuse PHILADELPHIA, April 15 /PRNewswire-USNewswire/ -- The University of Pennsylvania School of Medicine has been ranked #2 among the nation's research-oriented medical schools, according to the annual survey by U.S.
Contrary to popular belief, obese men and women do not receive inferior health care and are just as likely to receive preventative care from doctors.
A team of cardiologists, materials scientists, and bioengineers have created and tested a new type of implantable device for measuring the heart's electrical output that they say is a vast improvement over current devices.
PHILADELPHIA, March 18 /PRNewswire-USNewswire/ -- The University of Pennsylvania and AstraZeneca today announced a new collaborative research agreement to make use of their respective talents and resources in an effort to bridge the transition from drug discovery to development.